创新性前列腺内镜剜除术——谢氏前列腺剜除术
Innovative endoscopic enucleations of the prostate - Xie's Prostate Enucleations.
作者信息
Xie Liping, Wang Xiao, Chen Hong, Zheng Xiangyi, Liu Ben, Li Shiqi, Mao Yeqing, Mao Qiqi, Wang Song, Li Jiangfeng, Loch Tillmann
机构信息
Department of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, China.
Department of Urology, Diakonissenkrankenhaus Flensburg, Lehrkrankenhaus der Christian-Albrechts-Universität, Marienhölzungsweg, Flensburg, Germany.
出版信息
Asian J Urol. 2018 Jan;5(1):12-16. doi: 10.1016/j.ajur.2017.11.001. Epub 2017 Nov 20.
In the past 2 decades, endoscopic enucleation of the prostate has become a safe and effective surgical treatment for benign prostatic hyperplasia (BPH), with comparable outcomes to traditional surgeries. Transurethral vapor enucleation and resection of the prostate (TVERP), transurethral vapor enucleation of the prostate (TVEP), and ultrasound-navigated TVEP (US-TVEP) are new, innovative endoscopic enucleation procedures. These procedures are named Xie's Prostate Enucleations (Xie's Procedures for short). Current clinical data indicate that Xie's Procedures are safe and effective treatment options for patients with BPH, especially for patients with larger prostates. Further prospective, randomized clinical trials compared with traditional transurethral resection of prostate (TURP) are still needed.
在过去20年里，前列腺内镜剜除术已成为治疗良性前列腺增生（BPH）的一种安全有效的手术方法，其疗效与传统手术相当。经尿道前列腺汽化剜除术（TVERP）、经尿道前列腺汽化术（TVEP）和超声引导下经尿道前列腺汽化术（US-TVEP）是新型的创新性内镜剜除手术。这些手术被称为谢氏前列腺剜除术（简称谢氏手术）。目前的临床数据表明，谢氏手术对于BPH患者，尤其是前列腺较大的患者，是安全有效的治疗选择。仍需要进一步开展与传统经尿道前列腺切除术（TURP）对比的前瞻性随机临床试验。
Zotero 插件